Medical Tidbits, CORRECTING and REPLACING Takeda Provides Further Information about Its New Business Venture with Teva

glucose monitor

TAKEDA PROVIDES FURTHER INFORMATION ABOUT ITS NEW BUSINESS VENTURE WITH TEVA

Takeda Pharmaceutical Company Limited (TOKYO: 4502) and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) (TASE: TEVA) today made the below follow-up announcement regarding the overview of their new business venture in Japan, which was initially disclosed on November 30, 2015 in the press release titled, “Teva and Takeda establish unique partnership to meet the wide-ranging needs of patients and growing read more

Rich Pharmaceuticals, Inc. Receives FDA Approval for a Phase 1/2 Study in AML & MDS

BEVERLY HILLS, Calif., Dec. 28, 2015 /PRNewswire/ — Rich Pharmaceuticals, Inc. (OTC Markets: RCHA) (“Rich Pharmaceuticals” or the “Company”) is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration (FDA) to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients. The FDA has approved the Company’s Investigational New Drug (IND) application and has approved the Company’s commencement of a clinical program titled “A Phase 1/2, Evaluation of the Safety and Efficacy of RP-323 in Combination with all-trans-Retinoic Acid, Sodium Butyrate, and 1α, 25-dihydroxyvitamin D3 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)”. This approval gives the Company an immediate go ahead to start patient enrollment for a Phase 1/2 study using Rich Pharmaceuticals’ lead compound RP-323 in clinical trials.  read more

PixarBio Corporation Builds Regulatory Team Adding Steven Chartier, as Vice President of Regulatory Affairs, to Lead Non-Opiate, Non-Addictive Pain Treatment through the US FDA and European Regulatory Bodies

CAMBRIDGE, Mass.–(BUSINESS WIRE)–PixarBio Corporation announced today the appointment of Steven Chartier as V.P. of Regulatory Affairs. He will report to Frank Reynolds, the company’s Chief Executive Officer. Steve is another important piece to the company’s growing infrastructure, in maintaining momentum toward multiple FDA approvals of non-opiate and non-addictive pain treatments in early 2018. read more

Strategia Therapeutics Announces Progress in a Phase 1 Clinical Trial of the Anti-cancer Agent “FF-10501-01” for FUJIFILM in Patients with Advanced Hematologic Malignancies

BOSTON–(BUSINESS WIRE)–Strategia Therapeutics, Inc. (Strategia), is announcing progress in a Phase 1 clinical trial of FUJIFILM’s anti-cancer agent, FF-10501-01 in the United States in patients with relapsed or refractory myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The emerging results reveal that, in the Phase 1 dose escalation phase thus far (5 dose cohorts), FF-10501-01 has been highly tolerable and has demonstrated promising preliminary efficacy. read more

RegeneRx Joint Venture Posts Results of Severe Dry Eye Trial On ClinicalTrials.gov

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX)(“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that its joint venture with G-treeBNT, ReGenTree LLC, has posted final results from the first placebo-controlled, double-masked, exploratory Phase 2 clinical trial using RGN-259 eye drops in patients with severe dry eye on www.clinicaltrials.gov (search “thymosin and severe dry eye”), which were previously published earlier this year in the medical journal, Cornea; May 2015;34:491-496. read more

Julphar Glucose Monitoring Device DEXCOM G4 PLATINUM Now Available in GCC

The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and Lebanon. With this unique technology, diabetic patients can easily and conveniently monitor their glucose level around the clock. read more

Med Career News Medical Tidbits

Subscribe today for leading medical news and career advice from top medical recruiters!

Get Med Career News in your Inbox!

If you want to keep up with the latest news and career tips in the Medical Field subscribe today!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.